Brittany Alloway, DO General Practice Medicare: Accepting Medicare Assignments Practice Location: 10 Coburg Rd Ste 201, Eugene, OR 97401 Phone: 541-687-8581 Fax: 541-343-1411 |
Catherine Clinton, N.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 247 W 10th Ave, Eugene, OR 97401 Phone: 541-338-9494 |
Dr. Karen R Buntman, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 74 E 18th, Suite 1, Eugene, OR 97401 Phone: 541-343-8555 Fax: 541-343-8555 |
Thomas Francis Ryan, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1590 E 13th Ave, University Health Center, Eugene, OR 97403 Phone: 541-346-4447 |
News Archive
Young adults in Greece suffer more from stress and mental health problems and are less optimistic about the future than Swedes of the same age. The grave financial problems in Greece have brought on a social crisis that has probably affected people's health, according to a study from Link-ping University.
The amount of time teenagers spend on social networking sites has risen 62.5 percent since 2012 and continues to grow. Just last year, the average time teenagers spent on social media was estimated as 2.6 hours per day. Critics have claimed that more screen time is increasing depression and anxiety in teenagers.
Dr. Eric E. Whitaker, Illinois state public health director, is encouraging health care providers to work together to ensure that high-risk individuals get the flu shot.
A new study from Karolinska Institutet in Sweden shows that long-term endurance training in a stable way alters the epigenetic pattern in the human skeletal muscle. The research team behind the study, which is being published in the journal Epigenetics, also found strong links between these altered epigenetic patterns and the activity in genes controlling improved metabolism and inflammation.
KYTHERA Biopharmaceuticals, Inc. and Intendis, Bayer HealthCare's dermatology business, today announced that they have entered into a licensing agreement granting Intendis rights to KYTHERA's lead product candidate, ATX-101, outside of the US and Canada. ATX-101, a first-in-class investigational drug, is currently in clinical development for the reduction of localized fat under the chin (submental fat).
› Verified 4 days ago